Search - tctmd.com

Displaying 261 - 280 of 763

Sort: Relevancy | Date

Presentation TCT 2017

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Nicolo Piazza

October 31, 2017

Presentation TCT 2017

LOTUS Procedural Pearls (Including How NOT to Need a New Pacemaker)

Presenter: Nicolas M. Van Mieghem

October 31, 2017

Presentation TCT 2017

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Vinayak Bapat

October 31, 2017

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Presentation TCT 2017

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Presenter: Martin B. Leon, Changfu Wu, John C Laschinger

October 31, 2017

Presentation TCT 2017

LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates

Presenter: Michael J. Reardon

October 31, 2017

Presentation TCT 2017

Transpericardial Access for LAA Closure

Presenter: Stefan C. Bertog, Apostolos Tzikas, Krzysztof Bartus

October 31, 2017

Presentation TCT 2017

Case Presentation: No Reflow After Primary PCI

Presenter: David P. Faxon, Robert S. Schwartz, Mohamed Abdel-Wahab

October 31, 2017

Presentation TCT 2017

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, David W.M. Muller

October 31, 2017

Presentation TCT 2017

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Presenter: Hemal Gada

October 31, 2017

Presentation TCT 2017

Case #4: Paravalvular Leak Closure Using a Multifunctional Occluder Device

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Richard Nicandro R Torres

October 31, 2017

Presentation TCT 2017

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Presenter: David P. Faxon, Robert S. Schwartz, Stefan K. James

October 31, 2017

Presentation TCT 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Trans-septal Puncture for LAA Closure Using TEE Guidance

Presenter: Stefan C. Bertog, Apostolos Tzikas, Jacqueline Saw

October 31, 2017

Presentation TCT 2017

Established TMVR 2: Tiara - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Anson Cheung

October 31, 2017

Presentation TCT 2017

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

Presenter: John K. Forrest

October 31, 2017

Presentation TCT 2017

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

Presenter: David P. Faxon, Robert S. Schwartz, Raffaele Piccolo

October 31, 2017

Presentation TCT 2017

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Presenter: Azeem Latib, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

Presenter: Vladimir Dzavik, Navin K. Kapur, Nicolas M. Van Mieghem

October 31, 2017

Advertisement

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

LOTUS Procedural Pearls (Including How NOT to Need a New Pacemaker)

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates

Transpericardial Access for LAA Closure

Case Presentation: No Reflow After Primary PCI

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Case #4: Paravalvular Leak Closure Using a Multifunctional Occluder Device

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Trans-septal Puncture for LAA Closure Using TEE Guidance

Established TMVR 2: Tiara - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content